Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Cuker

Showing results (71-80 of 257) with videos related to

Pageof 26
Sort By:
British Journal of Haematology|May 15, 2014
DiagnoSTic assays for heparin-induced thrombocytopeniaElizabeth E Gardiner, Robert K Andrews, Adam Cuker
Plastic and Reconstructive Surgery|September 24, 2015
Microsurgery and the Hypercoagulable State: A Hematologist's PerspectiveChristopher J Pannucci, Stephen J Kovach, Adam Cuker
Current Opinion in Hematology|July 6, 2016
Controversies in the treatment of immune thrombocytopeniaAdam Cuker, Douglas B Cines, Cindy E Neunert
American Journal of Hematology|April 15, 2021
Comparative effectiveness and safety of anticoagulants for the treatment of heparin-induced thrombocytopeniaHenning Nilius, Jonas Kaufmann, Adam Cuker, et al.
Current Drug Safety|June 19, 2009
Safety of the thrombopoiesis-stimulating agents for the treatment of immune thrombocytopeniaAdam Cuker, Elaine Y Chiang, Douglas B Cines
Presse Medicale (Paris, France : 1983)|March 18, 2014
Pathogenesis of immune thrombocytopeniaDouglas B Cines, Adam Cuker, John W Semple
Journal of the American Heart Association|February 14, 2025
Direct Oral Anticoagulants Compared With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Without Mechanical ValvesGhadeer K Dawwas, James D Lewis, Adam Cuker
Journal of Evaluation in Clinical Practice|December 11, 2023
Improving methods of clinical practice guidelines: From guidelines to pathways to fast-and-frugal trees and decision analysis to develop individualised patient careBenjamin Djulbegovic, Iztok Hozo, Adam Cuker, et al.
Research and Practice in Thrombosis and Haemostasis|November 2, 2020
Second-line treatments and outcomes for immune thrombocytopenia: A retrospective study with electronic health recordsLincy S Lal, Qayyim Said, Katherine Andrade, et al.
Seminars in Thrombosis and Hemostasis|March 21, 2015
Can immune thrombocytopenia be cured with medical therapy?Adam Cuker, Eline T Luning Prak, Douglas B Cines
Pageof 26

Showing results (71-80 of 257) with videos related to

Sort By:
Pageof 26
British Journal of Haematology|May 15, 2014
DiagnoSTic assays for heparin-induced thrombocytopeniaElizabeth E Gardiner, Robert K Andrews, Adam Cuker
Plastic and Reconstructive Surgery|September 24, 2015
Microsurgery and the Hypercoagulable State: A Hematologist's PerspectiveChristopher J Pannucci, Stephen J Kovach, Adam Cuker
Current Opinion in Hematology|July 6, 2016
Controversies in the treatment of immune thrombocytopeniaAdam Cuker, Douglas B Cines, Cindy E Neunert
American Journal of Hematology|April 15, 2021
Comparative effectiveness and safety of anticoagulants for the treatment of heparin-induced thrombocytopeniaHenning Nilius, Jonas Kaufmann, Adam Cuker, et al.
Current Drug Safety|June 19, 2009
Safety of the thrombopoiesis-stimulating agents for the treatment of immune thrombocytopeniaAdam Cuker, Elaine Y Chiang, Douglas B Cines
Presse Medicale (Paris, France : 1983)|March 18, 2014
Pathogenesis of immune thrombocytopeniaDouglas B Cines, Adam Cuker, John W Semple
Journal of the American Heart Association|February 14, 2025
Direct Oral Anticoagulants Compared With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Without Mechanical ValvesGhadeer K Dawwas, James D Lewis, Adam Cuker
Journal of Evaluation in Clinical Practice|December 11, 2023
Improving methods of clinical practice guidelines: From guidelines to pathways to fast-and-frugal trees and decision analysis to develop individualised patient careBenjamin Djulbegovic, Iztok Hozo, Adam Cuker, et al.
Research and Practice in Thrombosis and Haemostasis|November 2, 2020
Second-line treatments and outcomes for immune thrombocytopenia: A retrospective study with electronic health recordsLincy S Lal, Qayyim Said, Katherine Andrade, et al.
Seminars in Thrombosis and Hemostasis|March 21, 2015
Can immune thrombocytopenia be cured with medical therapy?Adam Cuker, Eline T Luning Prak, Douglas B Cines
Pageof 26